Boston Scientific (BSX) EBITDA US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA, bln rub | ? | 1 511 | 2 518 | 2 741 | 3 620 | 3 453 | 3 737 | ||
Changes by years, y/y, % | -32% | +67% | +9% | +32% | -5% | +7.4% |
Boston Scientific. EBITDA US GAAP, bln rub
Boston Scientific. EBITDA US GAAP, changes, %
Boston Scientific. EBITDA US GAAP, sum by quarters, bln rub
Boston Scientific (BSX) EBITDA US GAAP (quarter values) |
||||||||
2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
EBITDA, bln rub | ? | 1 016 | 883.0 | 984.0 | 812.0 | 1 058 | 3 737 | |
Changes by years, y/y, % | +29% | +12% | +32% | +2% | +8% | |||
Changes by quarters, q/q, % | +4% | -13% | +11% | -17% | +30% |